Sign In  |  Register  |  About Menlo Park  |  Contact Us

Menlo Park, CA
September 01, 2020 1:28pm
7-Day Forecast | Traffic

  • Search Hotels in Menlo Park

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Pfizer (NY: PFE )

28.09 -0.21 (-0.74%)
Official Closing Price Updated: 7:00 PM EDT, Nov 1, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Pfizer

< Previous 1 2
...
5 6 7 8 9 10 11 12 13
...
99 100 Next >
What's Going On With Pfizer Shares Tuesday?
Pfizer reported top-line results of ABRYSVO, a novel vaccine, for respiratory syncytial virus (RSV) in immunocompromised adults. 
Via Benzinga
9 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
Long Covid Remains Diagnostic Mystery, Diagnosis Remains Elusive; National Institutes of Health-Funded Study Shows
A recent NIH study reveals no clear diagnostic test for Long Covid, highlighting ongoing challenges in identifying and treating the condition affecting millions of Americans. Researchers continue to... 
Via Benzinga
Exposures COVID-19
Pfizer Options Trading: A Deep Dive into Market Sentiment
Via Benzinga
3 Undervalued Low-Beta Stocks to Buy to Protect Yourself From Volatility
These are the undervalued low-beta stocks that have robust cash flow potential coupled with steady top-line growth. 
Via InvestorPlace
Market Whales and Their Recent Bets on PFE Options
Via Benzinga
Check Out What Whales Are Doing With PFE
Via Benzinga
Prediction: Buying Biotech and Pharma Stocks During This Sell-Off Will Be a Smart Move
There isn't much to suggest these businesses are actually vulnerable. 
Via The Motley Fool
Wall Street's Most Accurate Analysts Spotlight On 3 Health Care Stocks Delivering High-Dividend Yields
Via Benzinga
Novavax Plunges on Earnings Miss: Falling Knife or Buying Opp?
Novavax Inc. (NASDAQ: NVAX) is a biotechnology company that focuses on developing and commercializing vaccines for serious infectious diseases. 
Via MarketBeat
Exposures COVID-19
Pfizer's Respiratory Syncytial Virus Vaccine Data Shows Promise In Subgroup Of Younger Immunocompromised Patients
Pfizer's Abrysvo vaccine shows strong response against RSV in immunocompromised adults. 
Via Benzinga
Pfizer Announces Top-Line Results of ABRYSVO® for RSV in Immunocompromised Adults
From Pfizer Inc.
Via Business Wire
3 Reliable Dividend Stocks With Yields Above 5% That You Can Buy With $100 Now
A small investment in these stocks now could lead to heaps of dividend income by the time you retire. 
Via The Motley Fool
Is Pfizer Stock a Buy Now After Earnings?
This pharmaceutical blue chip could be ready to rally higher. 
Via The Motley Fool
Want to Earn $1,000 in Annual Dividend Income? Invest $11,300 in These 3 High-Yield Stocks
With an average yield above 8.9% at recent prices, investing in these stocks can do a lot to improve your passive income stream. 
Via The Motley Fool
As Traumatic Brain Injuries Increase, Global Concussion Market Size Expected to Reach $10 Billion By 2032
EQNX::TICKER_START (NYSE:OGEN),(NYSE:ABT),(NASDAQ:BIIB),(NYSE:PFE),(NYSE:ABBV) EQNX::TICKER_END 
Via FinancialNewsMedia
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
3 Dividend Stocks to Buy Now for a Winning Portfolio
Explore top dividend stocks for a steady income and reliable payouts, adding balance to your winning portfolio. 
Via InvestorPlace
Should Pfizer's Strong Quarter Calm Investor Concerns About the Stock?
Can this struggling stock turn things around? 
Via The Motley Fool
3 High-Growth Dividend Stocks to Own for the Next 10 Years
Discover the best high-growth dividend stocks with strong fundamentals across integrated telecommunication, retail REITs, and pharmaceuticals. 
Via InvestorPlace
The 7 Best Stocks to Buy in August 2024
Investors on the hunt for bargains among the current market volatility should consider these seven best stocks to buy. 
Via InvestorPlace
The 3 Best Biotech Stocks to Buy in August 2024
These biotech stocks are leading the way with groundbreaking therapies and robust fundamentals offering superb upside ahead. 
Via InvestorPlace
Here's Why Eli Lilly Stock Dropped 12% Last Month
News from a competitor gave investors an unwelcome dose of reality. 
Via The Motley Fool
Warren Buffett's Approach To Investing In Election Years
Warren Buffett, known as the 'Oracle of Omaha', is a highly successful American investor who manages his portfolio consistently, regardless of elections or market conditions. 
Via Benzinga
BioMedNewsBreaks — Annovis Bio Inc. (NYSE: ANVS) Release Promising Clinical Data As Global Alzheimer’s Disease Therapeutics Market Grows
Via Investor Brand Network
Forget Tech! 3 Value Stocks That Could Win Big From Rate Cuts.
Several value stocks are poised to benefit richly from upcoming rate cuts that could happen as soon as September when the Fed reconvenes. 
Via InvestorPlace
Topics Economy
Exposures Interest Rates
3 Dividend Growth Stocks to Buy Hand Over Fist in August
There are blue-chip bargains paying large and growing dividends in the healthcare space. 
Via The Motley Fool
Lucrative Incentive for Biotechs as Global Alzheimer’s Disease Therapeutics Market Forecasted to Reach $30.8 Billion By 2033
EQNX::TICKER_START (NYSE:ANVS),(NYSE:PFE),(NYSE:LLY),(NYSE:GSK),(NYSE:NVO) EQNX::TICKER_END 
Via FinancialNewsMedia
Lucrative Incentive for Biotechs as Global Alzheimer's Disease Therapeutics Market Forecasted to Reach $30.8 Billion By 2033
From FN Media Group LLC
Via GlobeNewswire
3 Cheap Stocks to Buy in August for Under $50
It is never too early or too late to start investing, so choose these cheap stocks under $50 to start building your portfolio. 
Via InvestorPlace
< Previous 1 2
...
5 6 7 8 9 10 11 12 13
...
99 100 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 MenloPark.com & California Media Partners, LLC. All rights reserved.